Anti-ERBB2 Therapeutic Antibody (Margetuximab)

Recombinant chimeric (mouse/human) antibody expressed in CHO binding to human ERBB2. Margetuximab is a monoclonal antibody designed for the treatment of cancer.
Supplier Creative Biolabs
Product # TAB-761
Pricing Inquiry
Host Mouse
Target ERBB2
Species Reactivity Human
Type IgG1 - kappa
Applications Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
Storage Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles.
Feedback